What is Infraredx?
Infraredx, Inc. is a specialized medical technology firm focused on the development of high-resolution intravascular imaging systems. The company's core portfolio, which includes the Clarispro HD-IVUS, Dualpro IVUS+ NIRS, and the Makoto Imaging System, provides clinicians with essential diagnostic insights for the management of vascular disease. By integrating advanced imaging modalities, Infraredx enables healthcare professionals to achieve superior patient outcomes through precise, data-driven cardiovascular care. The company operates at the intersection of biomedical engineering and clinical diagnostics, maintaining a robust market position by addressing the critical need for high-fidelity visualization in complex vascular procedures.
How much funding has Infraredx raised?
Infraredx has raised a total of $187.9M across 9 funding rounds:
Series A
$4.4M
Series B
$2.8M
Debt
$10M
Series D
$21M
Private Equity
$24.2M
Debt
$10M
Multiple Rounds
$115.5M
Series A (2003): $4.4M with participation from Sanderling Ventures
Series B (2005): $2.8M led by Sanderling Ventures
Debt (2010): $10M supported by Undisclosed
Series D (2010): $21M featuring Sanderling Ventures
Private Equity (2011): $24.2M, investors not publicly disclosed
Debt (2011): $10M with participation from GE Capital, Healthcare Financial Services
Private Equity (2013): $25M led by Nipro Corporation
Series C (2013): $70.5M supported by Nipro and Sanderling Ventures
Debt (2013): $20M featuring GE Capital, Healthcare Financial Services
Key Investors in Infraredx
Sanderling Ventures
Sanderling Ventures is a pioneering investment firm founded in 1979, specializing in building new biomedical companies. The firm has supported over 90 biomedical companies, focusing on early-stage financing and active management to achieve high rates of return for both entrepreneurs and investors.
Nipro Corporation
Nipro Corporation, headquartered in Osaka, Japan, has been a provider in medical products to the healthcare community for over 50 years. In addition to Nipro-branded products, Nipro provides manufacturing support to companies in the medical field.
GE Capital, Healthcare Financial Services
GE Capital, founded in 1932 and headquartered in Norwalk, Connecticut, operates as a holding company. The Company, through its subsidiaries, operates as a financial firm offering investment advisory services.
What's next for Infraredx?
With a solid foundation of capital, Infraredx is well-positioned to accelerate its commercial expansion and deepen its penetration into global healthcare markets. The strategic focus will likely shift toward enhancing the clinical utility of its existing imaging suite and potentially exploring new diagnostic applications for its proprietary technology. As the company moves beyond its current growth phase, the emphasis will remain on maintaining high-quality manufacturing standards and fostering strategic partnerships that extend the reach of its cardiovascular solutions. Continued investment in R&D will be paramount to sustaining its competitive advantage in the rapidly evolving medical device landscape.
See full Infraredx company page
